Sage Bionetworks Market Research Report

Company Overview

Name, Mission of the Company

Name: Sage Bionetworks
Mission: To drive a new age of discovery through truly open science and radical collaboration. Sage Bionetworks aims to enable a transformation in medicine through data sharing and reuse, fostering collective intelligence among diverse stakeholders.

Founding and Founders

Founded: 2009
Founders:

Stephen H. Friend, MD, PhD – Board Chair and Sage Co-Founder

Eric Schadt, PhD – Director and Sage Co-Founder

Key People

Luca Foschini, PhD: President & CEO

Kim Baggett, MPA: Chief Operating Officer

Christine Suver, PhD: Chief Privacy & Compliance Officer

Susheel Varma, BSE, MSc, PhD, MBA, FBCS: Chief Data Officer

Alberto Pepe, PhD: Vice President, Technology

Mackenzie Wildman, PhD: Chief of Staff

Headquarters

Location: Seattle, WA, USA

Number of Employees

No information is available.

Revenue

No information is available.

Company Expertise

Sage Bionetworks is known for being a trusted leader in data sharing and reuse, specifically in accelerating biomedical discoveries and transforming medicine through truly open science and radical collaboration.

Products

Synapse

Description: Synapse is a cloud-based data platform operated by Sage Bionetworks tasked with maximizing biomedical discovery. It's recognized as one of the only nine NIH-listed generalist repositories for scientific data.

Key Features:

AI Integration: Incorporates AI chat for enhanced data interrogation and innovative data reuse.

Data Storage: Custodian of 3.3 petabytes of data.

Monthly Activity: 6,200 active users.

Digital Twin

Description: A "digital twin" is a virtual model that utilizes a person’s health and biomedical data to simulate responses to medical interventions.

No further detailed information on the specific features of products is available.

Recent Developments

New Products and Features

Synapse AI Chat Integration (12/10/2024): Enables better interrogation of datasets. Provides precise searches, helpful summaries, and identification of new connections across datasets.

OpenChallenges.io (11/7/2023): A platform for aggregating biomedical challenges to accelerate citizen science and data benchmarking.

Recent Projects and Initiatives

CODA TB DREAM Challenge (1/26/2024): A continuous benchmarking platform for developing audio diagnostics for Tuberculosis through machine learning models.

BEAT-PD Challenge (5/30/2023): Focused on developing digital biomarkers for Parkinson’s Disease using wearable sensors.

Partnerships

Board Appointments (7/29/2024): Jennifer C. Goldsack and Brian J. Fox joined Sage Bionetworks’ Board of Directors to advance digital medicine and open-source software in biomedical research.

Additional Developments

MC2 Center (11/15/2022): Launched with the National Cancer Institute to improve collaboration and resource sharing in cancer biology.

Conclusion

Sage Bionetworks continues to advance open science and radical collaboration in biomedical research, with significant contributions in platforms like Synapse and new initiatives such as digital biomarker development for diseases. Through innovative projects and strategic appointments, Sage aims to overcome the challenges of data sharing for transformative impacts in healthcare.